Bartlett & Co Wealth Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.8K Hold
92
﹤0.01% 938
2026
Q1
$8.39K Hold
92
﹤0.01% 944
2025
Q4
$9.4K Hold
92
﹤0.01% 933
2025
Q3
$5.75K Hold
92
﹤0.01% 988
2025
Q2
$4.79K Hold
92
﹤0.01% 1006
2025
Q1
$3.92K Hold
92
﹤0.01% 1013
2024
Q4
$2.81K Hold
92
﹤0.01% 1020
2024
Q3
$2.11K Hold
92
﹤0.01% 1035
2024
Q2
$2.66K Buy
+92
New +$2.14K ﹤0.01% 1039

Other funds holding GH

Bartlett & Co Wealth Management's GH Position: Q2 2026 in Review

Bartlett & Co Wealth Management held its Guardant Health (GH) position steady in Q2 2026 at 92 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #938.

Bartlett & Co Wealth Management first reported a position in GH in Q2 2024 and has held it in 9 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Bartlett & Co Wealth Management held 92 shares of Guardant Health worth $13.8K as of Q2 2026.
  • Bartlett & Co Wealth Management left its Guardant Health share count unchanged in Q2 2026.
  • Guardant Health made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #938 holding.
  • Bartlett & Co Wealth Management first reported a position in Guardant Health in Q2 2024 and has held it in 9 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.